Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Textiles Press Releases.
Press releases published on May 31, 2025
Actuate Therapeutics Presents Topline Elraglusib Phase 2 Data at ASCO 2025 Annual Meeting: Trial Meets Primary Endpoint of Median Overall Survival and Doubles 1-Year Survival in First-Line Treatment of Metastatic Pancreatic Cancer
GlobeNewswire
·
May 31, 2025
Phase 2 (Actuate-1801 Part 3B) trial meets primary endpoint and demonstrates a clinically meaningful increase in median overall survival (10.1 months vs 7.2 months; log-rank p=0.01) in previously untreated patients with metastatic pancreatic ductal …
ALL ENHANCES ITS ENTERTAINMENT OFFERING WITH INTERNATIONAL PARTNERSHIPS
GlobeNewswire
·
May 31, 2025
FIRST PARTNERSHIP WITH OVO ARENA WEMBLEY IN ENGLAND RENEWED PARTNERSHIPS WITH MAJOR VENUES IN FRANCE, AUSTRALIA AND BRAZIL Since 2019, music has been one of the three main areas of interest for members of ALL, Accor's booking platform and loyalty programme …
Miracle Sheets: Do Miracle Antibacterial, Self-Cleaning Cooling Bed Sheets Really Work? Read Consumer Reports!
GlobeNewswire
·
May 31, 2025
New York City, NY, May 31, 2025 (GLOBE NEWSWIRE) -- Introduction – Why Bedding Hygiene Matters in 2025 When it comes to restful sleep, few people think about what’s actually lurking in their bed sheets. But over time, our bedding can become a silent host …
GA (Int’l) Capital Management Announces Launch of Communication Hubs
GlobeNewswire
·
May 31, 2025
HONG KONG, May 31, 2025 (GLOBE NEWSWIRE) -- GA (Int’l) Capital Management, a leader in tailored wealth management and investment services for high-net-worth individuals, is proud to announce the opening of satellite communication hubs in Germany, Belgium, …
XRP News: XenDex Presale Ends In 12 Hours, Join Presale Before $XDX Exchange Listing
GlobeNewswire
·
May 31, 2025
SYDNEY, May 31, 2025 (GLOBE NEWSWIRE) -- With only 12 hours remaining, the clock is ticking for investors to secure $XDX tokens at presale pricing. Once this final presale window closes, $XDX is expected to list on top-tier exchanges, with discussions …
Starscope: Does Starscope Monocular Really Work for Stargazing & Hiking? Read Full Starscope Monocular Telescope Consumer Report!
GlobeNewswire
·
May 31, 2025
San Diego, CA, May 31, 2025 (GLOBE NEWSWIRE) -- Introduction: Why the Starscope Monocular Is Gaining Popularity in 2025 Whether you're a nature lover, hiker, hunter, or stargazer, having the right optical gear can make or break your outdoor experience. In …
AI Meets XRPL: Nimanode’s $NMA Presale Gains Momentum as AI Agents Set to Transform Web3 Automation
GlobeNewswire
·
May 31, 2025
LEEDS, United Kingdom, May 31, 2025 (GLOBE NEWSWIRE) -- Nimanode, the trailblazing AI-powered platform built on the XRP Ledger, has officially launched its $NMA token presale, which started on May 22, 2025 and will remain live for a 30-day window. As XRP …
XRP News: $XDX Token Developed on XRP Nears Presale End in Just 12 Hours as Analysts Predict Major Surge Upon Exchange Listing
GlobeNewswire
·
May 31, 2025
SYDNEY, May 31, 2025 (GLOBE NEWSWIRE) -- With only 12 hours remaining before the XenDex $XDX presale closes, potential investors have a final opportunity to secure tokens at presale pricing. Analysts are forecasting a significant price surge once $XDX …
Gatorade 5v5 Finals Bring Global Youth to Champions League Stage in Munich
GlobeNewswire
·
May 31, 2025
MUNICH, Germany, May 31, 2025 (GLOBE NEWSWIRE) -- There was a palpable sense of excitement in Munich as the city prepared to host the UEFA Champions League final between PSG and Inter Milan. Fans from France and Italy – and much further afield – have been …
Robex gibt Abschluss des Börsengangs bekannt
GlobeNewswire
·
May 31, 2025
STADT QUÉBEC, May 31, 2025 (GLOBE NEWSWIRE) -- Der westafrikanische Goldproduzent und -erschließer Robex Resources Inc („Robex“ oder das „Unternehmen“) (TSX-V: RBX) freut sich bekannt zu geben, dass das Unternehmen den Börsengang an der Australian …
Robex annonce la finalisation de son introduction en bourse
GlobeNewswire
·
May 31, 2025
QUÉBEC, 31 mai 2025 (GLOBE NEWSWIRE) -- Robex Resources Inc. (« Robex » ou la « Société ») (TSX-V : RBX), producteur et développeur aurifère ouest-africain, a le plaisir d’annoncer le succès de son introduction sur la bourse australienne (« ASX ») avec 38 …
JAMining Expands FCA-Regulated Cloud Mining Services Amid Surging Crypto Market Activity
GlobeNewswire
·
May 31, 2025
Image by JAMining LONDON, May 31, 2025 (GLOBE NEWSWIRE) -- JAMining, a UK-based cloud mining provider regulated by the Financial Conduct Authority (FCA), has announced a major expansion of its services. This strategic move comes amid a surge in global …
Double Deposit Bonus, $50 Welcome Bonus & No-KYC 100x Leverage Trading Now Available on BexBack
GlobeNewswire
·
May 31, 2025
SINGAPORE, May 31, 2025 (GLOBE NEWSWIRE) -- As the price of Bitcoin surpassed the $100,000 mark and subsequently stabilized above $100,000, many analysts believe that it will enter a long-term high-volatility market. Holding spot positions may not continue …
PAIRMiner Makes Bitcoin Mining More Accessible Amid Market Surge
GlobeNewswire
·
May 31, 2025
Image by PAIRMiner STUTTGART, Germany, May 31, 2025 (GLOBE NEWSWIRE) -- As Bitcoin prices rise past key resistance levels, investor interest in digital assets is once again on the upswing. PAIRMiner, a cloud-based cryptocurrency mining platform, is helping …
Crypto Bubbles Come and Go: How Bitcoin Solaris’s Technology Aims for Stable, Long-Term Appreciation
GlobeNewswire
·
May 31, 2025
TALLINN, Estonia, May 31, 2025 (GLOBE NEWSWIRE) -- As Phase 5 of its limited presale nears completion, Bitcoin Solaris (BTC-S) is gaining momentum for all the right reasons. With its innovative Nova App poised for launch and over $1.2 million raised from …
Libtayo® (cemiplimab) Phase 3 Data in the Adjuvant Treatment of Post-Surgical High-Risk Cutaneous Squamous Cell Carcinoma (CSCC) Have Potential to Be Practice-Changing
GlobeNewswire
·
May 31, 2025
Libtayo demonstrated a 68% reduction in the risk of disease recurrence or death, the primary endpoint of the trial (p<0.0001) Libtayo also demonstrated 80% and 65% reductions in the risk of locoregional and distant recurrence, respectively, compared to …
Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/HER2- Advanced Breast Cancer
GlobeNewswire
·
May 31, 2025
Pivotal Phase 3 VERITAC-2 clinical trial results presented at ASCO demonstrate 2.9-month improvement in median progression-free survival when compared to fulvestrant in second line-plus patients with an estrogen receptor 1 mutation Vepdegestrant was …
Late-breaking analysis demonstrates characteristics associated with long-term overall survival with Onivyde® regimen in metastatic pancreatic adenocarcinoma
GlobeNewswire
·
May 31, 2025
Phase III NAPOLI 3 trial is the largest and has the longest follow-up for an interventional study in metastatic pancreatic adenocarcinoma1 Post-hoc analysis of NAPOLI 3 study determined characteristics associated with long-term survival, with median …
Une analyse « Late Breaking » démontre les caractéristiques associées à la survie globale à long terme des patients avec un adénocarcinome pancréatique métastatique traités par Onivyde®
GlobeNewswire
·
May 31, 2025
L’essai de Phase III NAPOLI 3 est la plus grande étude interventionnelle réalisée à ce jour avec la plus longue période de suivi des patients avec un adénocarcinome pancréatique métastatique1. L’analyse post-hoc de l’étude NAPOLI 3 a permis de déterminer …
Immatics IMA203 PRAME Cell Therapy Data Presented at 2025 ASCO Annual Meeting Continues to Show Strong Anti-tumor Activity and Durability in Patients with Metastatic Melanoma
GlobeNewswire
·
May 31, 2025
Extended Phase 1b trial follow-up on IMA203 PRAME cell therapy in 33 heavily pretreated patients with metastatic melanoma demonstrates favorable tolerability and promising clinical activity with ongoing deep and durable objective responses up to >2.5 years …